Dr. John Cush RheumNow
5 years 6 months ago
We are just two weeks out from RheumNow Live. There's still time to register. Attend virtually or in-person. CME credits available.
https://t.co/3zMtzt4t2H https://t.co/09Q5rRXsst
Dr. John Cush RheumNow
5 years 6 months ago
RheumNow Podcast – Pounds of Prevention
Dr. Jack Cush Reviews the news and journal reports from the past week on RheumNow. This podcast is sponsored by RheumNow Live.
https://t.co/4XSBysiVFW https://t.co/PREqOkyuM9
Incident or worsening colitis is a rare complication of IL-17 inhibitor therapy; a real world study confirms very low rates of new IBD in patients starting secukinumab.
Dr. John Cush RheumNow
5 years 6 months ago
Population study from Southern Norway shows the incidence of giant cell arteritis is not increasing. Over 13yrs, from pop of 300k they identified 206 GCA pts (72%females). Incidence rate of 16.8/100k per year. Mortality was not increased https://t.co/UA16uIuwD1
Genentech announced Thursday that the US Food and Drug Administration approved tocilizumab (Actemra) for the treatment of Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), specifically indicated for slowing the rate of decline in pulmonary function in adults SSc-ILD.
Dr. John Cush RheumNow
5 years 6 months ago
QD Clinic - RA and LFTs
NAFLD, NASH and Risks with DMARDs and MTX
https://t.co/LYV9WycEjz https://t.co/CMGtU4vclY
Dr. John Cush RheumNow
5 years 6 months ago
#RA associated interstifial lung dz has incidence of 1-5 per 1,000 PYs and prevalence as high as 67%; risk factors; age, male sex, Dz duration, CCP Abs; w/ age as best predictor of mortality. There is no clear drug interventions that helps RA-ILD https://t.co/zJvWqt0w6L
Dr. John Cush RheumNow
5 years 7 months ago
RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians.
Sign up to attend virtually or in-person today.
https://t.co/SvLpwNYh9c
Dr. John Cush RheumNow
5 years 7 months ago
Why it's safe to come to RheumNow Live. Lessons learned from restaurants and flying.
https://t.co/R0eYO2GiPd https://t.co/E9vPjzUTgb
Dr. John Cush RheumNow
5 years 7 months ago
News Feature: Actemra FDA Approved for Systemic Sclerosis Interstitial Lung Disease
https://t.co/6A4muejeH9 https://t.co/xQbIoEEscv
Dr. John Cush RheumNow
5 years 7 months ago
Download available--Difficult RA Defined
https://t.co/6WGMEiwiUk
Dr. John Cush RheumNow
5 years 7 months ago
RheumNow podcast now available! Listen on SoundCloud and Apple/Android podcasts.
https://t.co/P6kaqZP0PJ https://t.co/BPQ5Ey7d0r
Dr. John Cush RheumNow
5 years 7 months ago
"... think what others won’t think;
go where others won’t go;
do what others won’t do;
and be what others want to be."
- Phil knight
Dr. John Cush RheumNow
5 years 7 months ago
News Feature: Baricitinib Therapy in Covid-19 Pneumonia
https://t.co/b3tsLcoXay https://t.co/tjqkk1RLFZ
